Literature DB >> 1693276

Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer.

J G Guillem1, M F Levy, L L Hsieh, M D Johnson, P LoGerfo, K A Forde, I B Weinstein.   

Abstract

Our previous work on protein kinase C (PKC) and colon cancer has shown altered levels of PKC activity in human colon tumors, as well as activation of PKC by colon tumor promoters such as bile acids. To understand further the role of PKC in colon carcinogenesis, we analyzed the expression of phorbin, a gene induced by PKC activation, in a series of different stages of human colon tumors. As shown by northern blot analyses of poly (A)+ RNA, higher levels of phorbin RNA were seen in 26 colon tumor samples than in their adjacent normal colonic mucosa. There also appeared to be a correlation between the abundance of phorbin RNA in the tumors and the extent of invasion (tumor-to-normal tissue phorbin RNA ratio = 4.2, 8.0, and 11.9 for Dukes' A, B, and C, respectively). Phorbin RNA was also abundant in a human colon cancer line (HT29). We also examined the expression of other mitogen-responsive genes (c-myc, ODC, and beta-actin) in a set of 19 colon tumor samples. All tumors displayed significant (mean 3.8-fold) increases in the level of c-myc RNA compared with their adjacent normal colonic mucosa. About 47% and 16% of these tumor samples also showed increased levels of ODC (mean 3.1-fold) and beta-actin (mean 1.6-fold) RNA, respectively. The increased levels of c-myc, ODC, and beta-actin RNA did not correlate with the extent of tumor invasion. Taken together, these results demonstrate that human colon tumors usually display increased levels of both phorbin and c-myc RNAs. The marked increases in phorbin RNA suggest that this could serve as a useful biomarker in studies on human colon cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693276     DOI: 10.1002/mc.2940030204

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  12 in total

1.  Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts.

Authors:  T T Yang; S P Hawkes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 2.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

3.  RNA recovery efficiency for cultured cells and organ-derived cell suspensions.

Authors:  E S Berleth; B J Dolnick; M J Ehrke; E Mihich
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

4.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Role of protein kinase C in growth stimulation of primary mouse colonic epithelial cells.

Authors:  C Branting; R Toftgård; I P Hällström; J Rafter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

6.  TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.

Authors:  Hanne Offenberg; Nils Brünner; Francisco Mansilla; F Orntoft Torben; Karin Birkenkamp-Demtroder
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

7.  Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.

Authors:  S B Sobottka; M R Berger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells.

Authors:  M Baba; O Nakanishi; W Sato; A Saito; Y Miyama; O Yano; S Shimada; N Fukazawa; M Naito; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 9.  Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control.

Authors:  I B Weinstein
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

10.  Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.